Spero Therapeutics - 48 Year Dividend History | SPRO

Historical dividend payout and yield for Spero Therapeutics (SPRO) since 1971. The current TTM dividend payout for Spero Therapeutics (SPRO) as of June 17, 2019 is $0.00. The current dividend yield for Spero Therapeutics as of June 17, 2019 is 0.00%.
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.198B $0.004B
Spero Therapeutics Inc. is a multi-asset, clinical-stage biopharmaceutical company. It focused on identifying, developing and commercializing novel treatments for multi-drug resistant bacterial infections. Spero Therapeutics Inc. is based in CAMBRIDGE, United States.
Stock Name Country Market Cap PE Ratio
Amgen (AMGN) United States $107.397B 12.14
Gilead Sciences (GILD) United States $84.602B 10.27
Bio-Techne Corp (TECH) United States $7.890B 53.83